In Brief: Conmed
This article was originally published in The Gray Sheet
Executive Summary
Conmed: Completes proposed acquisition of Bristol-Myers Squibb's Linvatec/Hall orthopedic surgery subsidiary Dec. 31. Terms of the deal, which was announced in early December ("The Gray Sheet" Dec. 8, p. 13), include $370 mil. in cash and a 10-year warrant allowing BMS to purchase one million shares of Conmed common stock at $34.23 per share. Conmed will take a one-time charge in connection with the purchase...